news - CarboHyde

22nd International Cyclodextrin Symposium

Dec 10, 2025adminnewsconference, cyclodextrin

Moga, Punjab, India – ISF College of Pharmacy (An Autonomous College), Moga, is proud to announce that it will host the 22nd International Cyclodextrin Symposium (ICS22) from October 22-26, 2026. This marks a historic milestone as the first time this prestigious international symposium is being held in India.

The symposium, themed “Integrating Cyclodextrin and AI Techniques for Next-Generation Novel Drug Delivery Systems,” will bring together more than 500 leading scientists, researchers, academicians, and industry professionals from over 40 countries to discuss groundbreaking advances in cyclodextrin chemistry and its revolutionary applications in pharmaceutical sciences.

The symposium will cover diverse topics including:
# Cyclodextrin chemistry and characterization
# Novel drug delivery systems
# AI and machine learning in pharmaceutical formulation
# Nanotechnology applications
# Industrial perspectives and commercialization
# Regulatory aspects and quality control
# Clinical applications and case studies

When Cyclodextrin’s Two Homes Met in Kyoto

Nov 20, 2025adminnewscarbohyde, conference, cyclodextrin

Last week, Kyoto hosted the 12th Asian Cyclodextrin Conference, bringing together researchers, collaborators, and long-time friends from around the world — including several members of Bicyclos HEurope.

For us at CarboHyde, the event felt like a reunion between the two main “homes” of cyclodextrin science.
Japan has long been a cradle of CD innovation, while Hungary has become another strong home driving cyclodextrins toward new applications and industries. Seeing these two hubs reconnect in Kyoto was inspiring.

Our CSO, Milo Malanga, PhD, was also present — the smiling, chatty Italian in jeans who never misses the chance to ask a sharp question after each lecture. His presence helped spark new conversations and strengthen ongoing collaborations.

The conference offered what makes this community so special: solid science, meaningful dialogue, and friendships that push the field forward.

We return from Kyoto with renewed motivation — ready to turn last week’s ideas into future cyclodextrin innovations.

Career day in elementary

Nov 19, 2025adminnews, educationcarbohyde

Tamas Sohajda and his wife teaching 7-10 year-olders the wonders of pharmaceutics.

A little bit of industry, a bit of botanics, a bit of compounding, and the magic of chemistry via some spectacular experiments.

What could be more rewarding as a parent than seeing the sparkle in these little eyes?

Fight over the pipette (Hungarian sci-fi thriller)

Nov 18, 2025adminnewscarbohyde, IRL

Not sure what is going on here, but Pedro Vieira most certainly exploits all the learning potential during his GlyCanDrug MSCA-DN secondment in Budapest.

First he learned about the fluorescent labelling of cyclodextrins with Milo and now he is trained by Balazs in formulating his insoluble sugars – again, with cyclodextrins.

Finally, girl power!

Nov 18, 2025adminnewscarbohyde

It took us much longer than planned and than what we hoped, yet now we are on the right track.

We are super happy to have a bright young talent, such as Janka Juhász joining the CarboHyde team.

The cyclodextrin hard-core science space just became a bit more vivid and colorful.

Cyclodextrin Masterclass – Your time to shine

Nov 6, 2025adminnews, educationcarbohyde, masterclass, webinar

The Cyclodextrin Masterclass series has become a cornerstone for education and science communication in the field, fostering knowledge exchange and collaboration among researchers, students, and industry experts worldwide. Over its ten editions, it has helped bridge fundamental science and applied innovation, supporting the growth of the global cyclodextrin community and inspiring new generations of scientists.

As we approach the 10th edition, we invite researchers to present their cyclodextrin-related work in a 15-minute talk (10 min presentation and 5 min Q&A) at one of our upcoming Masterclasses.

If you’d like to share your research, please send a short abstract to tamas.sohajda@carbohyde.com.

Cyclodextrins at CPHI

Nov 5, 2025adminnews, Today's cyclodextrincarbohyde, CPHI, cyclodextrin

he world’s largest pharmaceutical exhibition, CPHI Worldwide 2025, took place in Frankfurt between 28–30 October, bringing together the global pharma community under one roof.

With more than 60,000 attendees, 2,400 exhibitors, and representatives from over 160 countries, the event once again showcased innovation across every sector — from ingredients and FDF to packaging, outsourcing, and biopharmaceuticals.

Cyclodextrins were once again in the spotlight. Key players exhibiting such as WACKER, Roquette, CarboHyde, and Zibo Qianhui Biological Technology Co., Ltd., Shandong Binzhou Zhiyuan Biotechnology Co., Xi’an DELI Biochemical Industry Co, together with distributors like Ashland and Barentz, represented the backbone of the CD industry.

Numerous pharma companies also highlighted cyclodextrin-enabled formulations, including Sugammadex API producers and integrated CD-based drug delivery innovators.

CarboHyde was proud to be part of it all — represented by Daniel Bisericaru, Balázs Kondoros, Tamás Vargadi, and Tamás Sohajda — meeting partners, exploring new ideas, and strengthening collaborations around next-generation cyclodextrin projects.

We have seen – beyond the traditional applications – interest in nutraceutical, wound healing, mucoadhesive, vaccine, protein, targeted drug delivery and many applications.

Thank you to everyone we met in Frankfurt — your passion and insights continue to drive the evolution of CD science and its pharmaceutical applications.

See you next year in Milan!

CarboHyde Cyclodextrin Masterclass X – Cyclodextrins as Active Ingredients

Oct 27, 2025adminnews, educationcarbohyde, cyclodextrin, cyclodextrin masterclass

The upcoming CarboHyde Cyclodextrin Masterclass will focus on the emerging role of cyclodextrins (CDs) as active pharmaceutical ingredients (APIs), highlighting how these versatile molecules are moving beyond their classical excipient role into the therapeutic spotlight. Through landmark examples such as Sugammadex, a CD-based neuromuscular blockade reversal agent, and hydroxypropyl-β-cyclodextrin (HPβCD) in the treatment of Niemann-Pick Type C disease, participants will gain insight into how the unique host–guest chemistry of CDs translates into clinical efficacy.

The session will further explore next-generation applications of CDs, including their use as scavengers for drug overdose, and their potential in new therapies for widespread conditions such as Alzheimer’s disease and atherosclerosis, as well as rare diseases including Kabuki syndrome and focal segmental glomerulosclerosis (FSGS). The discussion will cover mechanistic aspects—how CDs modulate biological pathways and molecular interactions—alongside chemical design strategies, drug discovery approaches, and regulatory and Chemistry–Manufacturing (CM) considerations essential for translation into approved therapies.

This Masterclass will provide researchers, developers, and industry professionals with a comprehensive perspective on cyclodextrins as therapeutic agents, bridging molecular innovation with real-world drug development challenges and opportunities.

Register now – before it’s too late to uncover how cyclodextrins are redefining therapeutics!